The AAA-ATPase p97/VCP forms complexes with different adapters to fulfill distinct cellular functions. We analyzed the structural organization of the Ufd1-Npl4 adapter complex and its interaction with p97, and compared it to another adapter, p47.
Introduction:
The essential AAA ATPase p97/VCP (valosin-containing protein) in vertebrates and its orthologues in yeast (Cdc48p) and other organisms are involved in a large variety of cellular processes. These include organelle membrane fusion, removal of soluble and membrane proteins, regulation of gene expression, cell cycle and apoptosis (1) . p97 functions as a molecular chaperone that either extracts substrates from membranes and other structures or changes their conformation. It contains two AAA domains (D1 and D2) that are stacked and form a hexameric barrel. The N-domain, which interacts with cofactors and substrates, is positioned in a plane with D1 at the outside of the hexamer (2) (3) (4) . Functional and structural work suggest that nucleotide hydrolysis and exchange in the D2 domain causes movements within the molecule, particularly of the N-domain (5) (6) (7) (8) . These movements may then be transmitted, directly or indirectly, onto substrate proteins to apply mechanical force.
For its various functions, p97 cooperates with different sets of mutually exclusive adapters and additional cofactors. Two of which, p47 (9) and a binary complex of Ufd1 and Npl4 (10) have been extensively studied, and a growing number is being discovered (1). Ufd1-Npl4 and p47 form alternative complexes with the ATPase and are required for different types of reactions.
The Ufd1-Npl4 adapter is needed for p97-mediated reactions during ER-associated degradation (ERAD) (11) (12) (13) (14) , nuclear envelope formation (15) , spindle disassembly after mitosis (16) and, in yeast, in the proteasome-dependent activation of transcription factors (17, 18) . During ERAD, p97 and Ufd1-Npl4 mediate the transport of ER proteins into the cytosol for subsequent degradation by the ubiquitin-proteasome system. This mobilization process involves the recognition of a substrate in the membrane by the p97-Ufd1-Npl4 complex, followed by its ATP hydrolysis driven extraction and concomitant ubiquitylation (6) . The function of Ufd1-Npl4 depends on the N-terminal 200 amino acids in Ufd1 that adopt the same fold as the p97 Ndomain (19) and bind lysine-48-linked poly-ubiquitin chains (6) . The Npl4 zinc finger (NZF) domain at the C-terminus of metazoan Npl4 also binds ubiquitin (20) (21) (22) .
The p47 adapter, on the other hand, contains three domains, a C-terminal ubiquitin-fold UBX (ubiquitin regulatory X) domain that binds p97, a SEP (shp1, eyc, p47) domain of unknown function and a UBA (ubiquitin-associated) domain at the N-terminus that binds ubiquitin (21, 23, 24) . The p97-p47 complex regulates several organelle membrane fusion steps including cisternal regrowth from mitotic Golgi fragments (9) . This process involves ubiquitin, but -in contrast to ERAD -is proteasome-independent. p97-p47 is recruited to a mono-ubiquitylated, yet unidentified substrate on mitotic Golgi membranes via the UBA domain in p47 (21) . There, it cooperates with another cofactor, the deubiquitinating enzyme VCIP135, to remove ubiquitin and trigger membrane fusion (25, 26) .
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The exact functions of the adapters and how they modulate p97-mediated reactions are not fully understood. One aspect is that they link the ATPase to different types of ubiquitin-conjugates, Ufd1-Npl4 to lysine-48 linked chains and p47 to mono-ubiquitylated substrates (6, 21) . Another aspect is the p47-mediated regulation of the ATPase activity of p97 (27) . In an effort to cast light on the role of Ufd1-Npl4 and its relationship to p97, we have analyzed its structural organization and its interaction with the ATPase. Surprisingly, we found that it is very similar to p47.
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Experimental procedures:
DNA constructs and expression of proteins
All proteins were generated in Escherichia coli. Full-length His-p97, Npl4 and Ufd1-His were generated and complexes assembled as described (10, 15) . Constructs coding for truncation mutants of Ufd1, Npl4 and p47 fused to the C-terminus of GST were derived from pGEX-Ufd1, pGEX-Npl4 and pGEX-p47 (10), respectively, and generated by Quickchange mutagenesis followed by confirmation of the entire sequence. The ubiquitin-fold domain of Npl4 with a Cterminal His-tag was expressed using pET30 (Novagen) that contained an insert between the NdeI and XhoI sites coding for amino acid 1-96. The His-tagged p47 full-length, p47-UBX and p47(BS1-UBX) proteins were expressed using pTrcHis-p47 (10) or derived constructs coding for aa 1-370, 282-370 and 244-370, respectively. His-tagged and GST-tagged fusion proteins were purified using Ni-agarose (Qiagen) or glutathione-sepharose (Amersham Biosciences), respectively. GST-p97 and His-p47 variants were further purified using gel filtration. Peptides covering BS1 of Ufd1 (GEVGFRAFSGSGNRLDGKKKG) and p47 (PKGAFKAFTGEGQKLGSTAPQ), and Ufd1(286-306) were synthesized and biotinylated at the N-terminus.
Molecular mass determination:
The Ufd1-Npl4 complex was generated from recombinant proteins as described (15) . 70 µg of 
Binding experiments
For experiments using gel filtration, the preassembled Ufd1-Npl4 complex or individual proteins were either run alone or after 30 min binding on ice in running buffer (150 mM KCl, 25 mM Tris pH 8.0, 2.5 MgCl 2 , 1 mM ATP, 5% glycerol) followed by separation on a Superose-6 HR (10/30) column (Amersham Biosciences). Co-precipitation experiment using glutathione-or streptavidin coated beads were performed as described (10) . Competition experiments were carried out with 50 times molar excess of soluble UBD/UBX domains or BS1 peptides over immobilized binding domains. An anti-His antibody (Amersham Biosciences) was used to detect p47 variants co-isolated with GST-p97. Far western overlay assays were carried out as described (10) .
Sequence analysis
Primary peptide sequence alignment was performed using the CLUSTAL W program (28).
Secondary structure was calculated using Jpred (http://www.compbio.dundee.ac.uk/~www-jpred/) (29) . Protein fold recognition was done with 3D-PSSM (http://www.sbg.bio.ic.ac.uk/~3dpssm/) (30) .
ATPase assay
The assays were performed using 2 µg recombinant p97 preincubated without or with varying amounts of the p47, p47 (244-370) or Ufd1-Npl4 for 30 min on ice. Proteins were then incubated in 100 µl buffer (50 mM HEPES pH7.4, 150 mM KCl, 2.5 mM MgCl 2 , 5% glycerol and 2mM ATP) for 40 min at 37°C. 40µl samples were taken at the start and the end of the reaction. Formation of orthophosphate was measured using the malachite green color reagent according to the method by Lanzetta et al. (31) .
Results

:
Ufd1 and Npl4 form a hetero-dimer
In a first step towards understanding the structural organization of the Ufd1-Npl4 complex and its interaction with p97, we determined the stoichiometry of the adapter. Our previous data suggested that Ufd1 and Npl4 form a tight complex with a ratio of 1:1. The binary complex eluted at an apparent molecular weight of 200 kDa from gel filtration both when isolated from cytosol as well as when reconstituted from recombinant proteins (10) . However, since migration in size exclusion columns depends on both size and shape of the proteins, we determined the molecular weight of the reconstituted Ufd1-Npl4 complex by coupling gel filtration with in-line multi-angle laser light scattering, refractive index and ultraviolet light measurements. The Ufd1-Npl4 peak was monodisperse with an average molecular weight of 100 kDa (data not shown). This is in agreement with a hetero-dimer composed of one Npl4 (67 kDa) and one Ufd1 (35 kDa) peptide.
We also previously showed that Ufd1 alone binds p97. However, Npl4 stimulates complex formation, even though it does not bind p97 on its own in solution (10) . To reveal the relevance of this stimulation, we performed binding experiments with p97 to Ufd1 or Npl4 individually, or Ufd1 and Npl4 together, separated the resulting protein complexes by gel filtration and analyzed them in SDS-polyacrylamide gels (figure 1). Ufd1 bound p97, but binding was inefficient, since only a fraction of p97 was shifted to a larger molecular weight (row 2). More importantly, the p97-Ufd1 complexes were of heterogeneous size and some eluted in the void volume, indicating that the proteins aggregated. Consistent with previous results (10,15), Npl4 did not bind p97 (row 3), whereas Ufd1-Npl4 bound p97 efficiently and shifted it homogeneously to an apparent molecular weight of about 700 kDa (row 5). These results show that Ufd1 requires Npl4 for correct complex formation with p97.
Ufd1 contains two distinct bindings sites for Npl4 and p97
Ufd1 binds both p97 and Npl4 via its C-terminal ~100 amino acids, previously termed the UT6 domain (15) . We decided to clarify whether p97 and Npl4 bind via the same or distinct interaction sites within this domain. Binding of the two partners to Ufd1 can be analyzed in farwestern overlay assays. We generated a series of Ufd1 truncation mutants fused to GST in bacteria as depicted in figure 2 A. Bacterial lysates were separated in SDS gels and transferred onto membranes. After partial renaturation, immobilized proteins were incubated with biotinylated p97 or Npl4, respectively. Bound probes were identified with peroxidase-coupled steptavidin and detected by chemiluminescence. The results are summarized in figure 2 A. We found that Ufd1 contains two distinct short binding sites for p97 and Npl4, lying between residues 215-241 (termed binding site 1 [BS1] from here on) and 258-275, respectively. To confirm the results from overlay assays, we purified critical truncation mutants and performed binding assays with p97 or Npl4 in solution. We also generated and tested GST-Ufd1(281-307), which contains a sequence with homology to BS1. GST-Ufd1 mutant proteins were isolated using immobilized glutathione and bound partners analyzed in Coomassie-stained SDS gels (figure 2 B). Our results show that Ufd1(215-241) was necessary and sufficient to bind p97, but did not interact with Npl4. Conversely, Ufd1(258-275) bound Npl4, but not p97. The internal repeat Ufd1(281-307) did not bind either of the two partners.
Sequence alignment of Ufd1-BS1 with p47 revealed a short homologous stretch in the larger linker region between the p47 SEP and UBX domains, which had previously been implicated in interaction with p97 (26) . The hydrophobic residues are best conserved between the two sequences (figure 2 C). To confirm the relevance of the homology, we used chemically synthesized peptides covering the BS1 sequences of Ufd1 and p47 as shown in figure 2 C.
Peptides were biotinylated at the N-terminus and immobilized on steptavidin-beads. Incubation with p97 and subsequent co-sedimentation revealed that both peptides bound p97 specifically (figure 2 D). In summary, we found that Ufd1 has two distinct short binding sites for p97 and Npl4. The first one, BS1, covers 21 amino acids and is homologous to a newly demarcated binding site in the other adapter, p47. An independent binding site for Npl4 resides further down-stream covering 18 amino acids.
Interaction with Ufd1 activates Npl4 binding to p97
The identification of the two distinct binding sites in Ufd1 allowed us to analyze Npl4-stimulated complex formation with p97. Again, we performed in vitro interaction studies with GST-Ufd1 truncation mutants binding to Npl4 or p97, but this time also with Npl4 and p97 together. As before, bound partners were detected in SDS gels (figure 3). Like in the previous experiment, GST-Ufd1(1-230) covering the N-terminal domain did not bind any of the partners (lanes 1-3), whereas GST-Ufd1(215-307) bound both (lanes 4 and 5). Confirming our previous data, p97 recruitment to the latter was stimulated by co-incubation with Npl4 (lane 6). Ufd1-BS1 (215-241) bound p97, but not Npl4, no matter whether incubated individually or together (lanes 7-9). Conversely, the Ufd1-Npl4 binding peptide (258-275) only bound Npl4, but not p97 (lanes 10 and 11). Despite the lack of direct binding activity to p97, however, this fragment co-sedimented p97, when Npl4 was present (lane 12). This result suggests that the binding of the Ufd1 fragment to Npl4 activated an otherwise inactive interaction domain in Npl4 for p97, and that Npl4 bridged between GST-Ufd1(258-275) and p97 in this reaction.
Npl4 contains a ubiquitin-fold domain that mediates interaction with p97
The notion of a hidden p97 interaction domain in Npl4 is supported by the fact, that p97 binds partially denatured Npl4 on filters in overlay assays (10) . We used the same technique to search for the p97-binding site in Npl4. As for Ufd1, we generated a series of Npl4 truncation mutants fused to GST as listed in figure 4 A. We expressed the Npl4 mutants in bacteria and analyzed the lysates in far-western assays with biotinylated p97 in the overlay. As shown in figure 4 B, we identified a fragment covering the N-terminal 89 amino acids that was sufficient and required for interaction with p97. In contrast, other mutants that either covered only residues 1-49 or were missing the N-terminal 47 amino acids were unable to interact with p97. Binding of p97 to these mutants was also tested in solution confirming the results obtained in overlay assays (data not shown).
In our hands, standard computational sequence analysis of the Npl4 N-terminus did not reveal significant homologies to any known proteins (other than Npl4 orthologues) or conserved domains. A fold recognition method, however, used on the 3D-PSSM server (http://www.sbg.bio.ic.ac.uk/~3dpssm/) predicted a ß-grasp fold that is also found in ubiquitin and related proteins. Since p47 binds p97 via its UBX domain that also assumes a ubiquitin-fold (23,32), we aligned the peptide sequences of the two domains according to their predicted (Npl4) or confirmed (p47) secondary structure and relatively weak primary sequence similarities (figure 4 C) .
Dreveny and colleagues (33) showed that the p47-UBX domain interacts with p97 by inserting the loop between its strands 3 and 4 into a cleft in the p97-N-domain. Furthermore, they identified an arginine on strand 1 to be important for binding. We tested whether the Npl4 ubiquitin-fold domain (UBD) binds via the same mechanism to p97. We generated a series of variants of the Npl4-UBD fused to GST with mutations in critical residues and tested binding to contains an interaction domain for p97 that assumes a ß-grasp ubiquitin-fold (UBD), but has little primary sequence homology to either ubiquitin or p47-UBX. Nevertheless, both interaction domains employ the same surfaces for binding to p97.
Binding sites in Ufd1 and Npl4 are functionally related to individual sites in p47
We identified two different binding sites in the Ufd1-Npl4 adapter that are homologous to binding sites in p47. We therefore wanted to clarify whether the different sites can interact independently and whether the homologous sites in the two adapters bind via similar mechanisms.
We incubated p97 again with GST-fusions of each of the binding domains, Npl4-UBD, p47-UBX, Ufd1-BS1 or p47-BS1. We then tested the interaction in two series of competition experiments. First, we carried out the binding in the absence or presence of excess amounts of His-tagged ubiquitin-fold domains, Npl4-UBD or p47-UBX ( figure 5 A) . In the second series, we performed the same set of binding reactions, this time in the absence or presence of excess peptides covering the other binding site of each adapter, Ufd1-BS1 or p47-BS1 ( figure 5 B) .
Analysis of the amounts of p97 co-sedimented with the GST-fusions under the different conditions revealed that each ubiquitin-fold domain interfered with binding of both Npl4-UBD and p47-UBX (A, lanes 3-4 and 6-7), but not with interaction of the BS1 of either of the two adapters (A, lanes 9-10 and 12-13). Conversely, the BS1 peptides of either Ufd1 or Npl4 inhibited p97 binding to the immobilized BS1 of both adapters (B, lanes 9-10 and 12-13), but did not affect interaction of the UBD/UBX domains with p97 (B, lanes 3-4 and 6-7).
Together, these data show that the two binding domains of each adapter independently interact with p97. However, homologous domains of the adapters compete for binding suggesting that they bind via the same mechanism to p97.
The binding domains alone do not mediate regulation of ATPase activity
We previously reported that p47 down-regulates the ATP hydrolysis activity of p97 (27) . Since results presented here revealed that Ufd1-Npl4 uses the same mechanism of interaction with p97 as p47, we asked whether Ufd1-Npl4 regulates p97 the same way. When we measured p97-adapter complexes, however, we found that, contrary to p47, Ufd1-Npl4 did not reduce the ATPase activity of p97 ( figure 6 ). This differential effect could have two reasons. It could be due to small variation in the binding regions between the two adapters. Alternatively, the binding domains of p47 do not regulate p97 directly, but require additional adapter-specific domains for the modulation. We, therefore, tested whether the p47(244-370) fragment that contains both BS1 and the UBX domain, but lacks the p47 specific domains, had any regulatory activity. Despite 16 the fact that the p47 fragment bound p97 as well as full-length p47 in co-sedimentation experiments (figure 6 B), we did not observe a negative effect on the ATPase activity caused by the mutants at equimolar concentrations (figure 6 A) or even at five times molar excess (not depicted). Therefore, the bipartite binding domain of the adapter does not regulate p97 activity directly, but requires additional adapter-specific domains.
Discussion:
Recent work has revealed that p97/VCP mediates different types of reactions and that it requires distinct sets of cofactors to carry out these tasks. In this report, we found that despite these functional differences and lack of overall homology, the two alternative adapters Ufd1-Npl4 and p47 interact with the ATPase in a very similar manner via a bipartite binding mechanism ( figure   7 ).
In the case of Ufd1-Npl4, each of the two subunits contains one binding site and several lines of evidence show that both subunits indeed act together and bind p97 cooperatively. We have previously shown that, although Ufd1 can interact with p97 independently, the addition of Npl4 stimulates complex formation. By analyzing the various possible complexes more carefully, we now show that p97 binding to Ufd1 alone results in inefficient binding that leads to heterogeneous complex formation and aggregation. Only the pre-assembled Ufd1-Npl4 complex efficiently binds p97 and forms a physiological ternary complex of homogeneous size that is also found in cytosol, suggesting that all three partners act together. We also revealed how Npl4 stimulates complex formation even though it is not able to bind p97 on its own in solution.
Using truncation mutants, we showed that Ufd1 binding to Npl4 activates a ubiquitin-fold domain (UBD) in Npl4 that then interacts with p97. The notion of an auto-inhibited binding of full-length, free Npl4 is supported by the fact that the isolated UBD of Npl4 can bind p97 in solution, and so does partially denatured Npl4 on filters. Whether this activation by Ufd1 is physiologically relevant is unclear, since we have not detected Ufd1 or Npl4 individually in cell extracts.
Our analysis of the reconstituted, binary Ufd1-Npl4 complex using multi-angle light scattering combined with gel filtration revealed that the adapter is a hetero-dimer with only one molecule of each protein. It, therefore, has the same layout of binding sites as a single p47 molecule. The fact that Ufd1-Npl4 elutes at a larger apparent molecular weight from gel filtration columns points at an elongated shape of the complex. Based on these findings, any number of Ufd1-Npl4 between 1 and 6 could theoretically bind a single p97 hexamer, although a symmetric interaction of either 3 or 6 units per hexamer may be more likely. In the case of p47, recent findings indicate a binding ratio of 6 adapter molecules per hexamer p97 (33, 34) , but further structural and functional work is required to confirm these results and clarify whether this is also true for Ufd1-Npl4.
The finding of a UBD in Npl4 as a binding site for p97 was unexpected to us, since primary sequence analysis did not detect any obvious homologies to ubiquitin or ubiquitin-like domains.
We could, however, identify this domain using fold prediction software in Npl4 proteins as distantly related as the mammalian and the yeast form. This prediction is supported by our binding analysis using mutants of the Npl4-UBD. It revealed identical interaction surfaces with p97 as those reported for the p47-UBX domain (33) . Our data, therefore, suggest that the described complex represents a general interaction mechanism of ubiquitin-fold domaincontaining cofactors with p97. This is not the same mechanism as employed for the interaction of ubiquitin-chains with p97, though, since cofactors and ubiquitin do not significantly compete for binding to the ATPase (33, 35) . This is consistent with our results that Ufd1-Npl4 or p47 stimulate ubiquitin binding to p97 rather than inhibiting it (6, 21) . Furthermore, the absence of significant sequence homology to ubiquitin makes it unlikely that the Npl4-UBD acts in a similar manner as the truly ubiquitin-like domains in Rad23 and related proteins that link these factors to the proteasome (36) . The sole function of Npl4-UBD may therefore be the interaction with p97.
The identification of the UBD in Npl4 as the interaction interface for p97 associates the Ufd1-Npl4 complex with a growing number of cofactors that bind p97 via this fold. Besides p47, these include VCIP135 in mammals (Uchiyama, 2002) , Ubx1-7p in budding yeast (37, 38) and Ubx2p and Ubx3p in fission yeast (35) . The fold does not seem to be a prerequisite for interaction, though, since we did not detect this domain in the direct binding partners such as Ufd3p or Ufd2p using fold prediction.
Ufd1, on the other hand, contains a short hydrophobic binding site for p97 (BS1). We show that it is homologous and functionally related to a short stretch in p47 within the linker between the 20 SEP and UBX domains that was previously shown to bind p97 (26) . The BS1 does not seem to be as common as the ubiquitin-fold, though. We noticed a homologous region in VCIP135 (amino acids 1020-1035) and it will be interesting to find out whether it has the same function.
However, none of the other known p97-binding factors have segments with obvious homology to BS1. Nevertheless, BS1 is conserved in Ufd1 proteins of different species. This is also true for C. elegans Ufd1, which is intriguing, since Npl4 in this species lacks the UBD.
Given that the N-domain of p97 is essential for adapter binding (6) , it is likely that BS1, too, directly interacts with it. Unfortunately, the structural data collected by Deverny et al. (33) using the p47(244-370) fragment that contains both UBX and BS1 did not reveal the exact location of its binding site in p97. The orientation of the fragment in the crystal with p97, however, suggests that BS1 binds p97 on the top of the N-domain towards the center of the p97-hexamer. Based on our finding that the two binding sites interact independently with p97, one could speculate that p47(244-370) or Ufd1-Npl4 form a clamp around the N-domain. It was, therefore, important to ask whether the connected binding domains alone account for the down-regulation of p97 ATPase activity as observed for p47, by either changing the conformation of p97 or restricting the movements of the N-domains. However, since we did not detect any effect on the rate of ATP hydrolysis upon binding of either p47(244-370) or the complete Ufd1-Npl4 complex, we conclude that bipartite adapter binding does not regulate the ATPase activity directly. Therefore, the additional adapter moieties and the way they organize the p97-adapter complexes are crucial for the differential regulation. In fact, p47 has been reported to oligomerize (24) . Oligomerization of p47 units within the p97-adapter complex may be another way of restricting N-domain movements and thereby influencing ATP hydrolysis. Consistent with this, there is no evidence for oligomerization of Ufd1-Npl4. These results support a model in which the binding domains of the adapters serve as anchor points for p97 rather then directly regulating it, whereas adapter-specific domains are required for differential modulation.
Correct anchoring, though, may be crucial. Whereas the UBD could serve as a general recruitment domain, the BS1 may provide higher affinity and may position the adapter in the right orientation with respect to p97 and its movements. The exact role of the adapters in p97-mediated reactions is still a matter of speculation. If they are involved in transmitting mechanical force from p97 to a substrate, correct positioning is essential. However, this is also true, if they are involved in further processing of substrates and regulating recruitment of additional cofactors, a deubiquitinating enzyme in the case of p47, and possibly ubiquitin-conjugation machinery in the case of Ufd1-Npl4. Future analysis of yet uncharacterized domains of the adapters will shed light on their roles in p97-mediated reactions. GST-tagged ubiquitin-fold domains of Npl4 and p47 (UBD and UBX, respectively), or the binding site 1 (BS1) of Ufd1 and p47 were mixed with p97 as indicated. Each combination was incubated in the absence or presence of either excess His-tagged Npl4-UBD or p47-UBX proteins (panel A), or excess Ufd1-BS1 or p47-BS1 peptide (panel B) as competitors. GSTfusions were sedimented and bound protein analyzed in Coomassie-stained SDS gels. 10 % of input p97 is shown at the bottom of each panel. GST alone was used as a negative control. Note that each of the two ubiquitin-fold domains compete with both Npl4-UBD and p47-UBX, but not with the BS1 versions, and vice versa. (A) p97 complexes were formed by preincubating p97 with equal mol amounts of p47, the p47 (244-370) fragment containing both BS1 and UBX, or Ufd1-Npl4 on ice for 30 min. The ATP hydrolysis activity of the complexes was then measured at 37ºC. Shown is the mean of three experiments.
(B) Equal binding affinities of p47 and p47 (244-370) to p97 were confirmed by coprecipitation experiments. GST or GST-p97 were incubated with either of the two His-tagged p47 variants and bound protein was analyzed by immuno-blotting using an anti-His antibody. 
